Rac1 and AMPK account for the majority of muscle glucose uptake stimulated by ex vivo contraction but not in vivo exercise
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Rac1 and AMPK account for the majority of muscle glucose uptake stimulated by ex vivo contraction but not in vivo exercise. / Sylow, Lykke; Møller, Lisbeth Liliendal Valbjørn; Kleinert, Maximilian; D'Hulst, Gommaar; De Groote, Estelle; Schjerling, Peter; Steinberg, Gregory R; Jensen, Thomas Elbenhardt; Richter, Erik A.
In: Diabetes, Vol. 66, No. 6, 2017, p. 1548-1559.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Rac1 and AMPK account for the majority of muscle glucose uptake stimulated by ex vivo contraction but not in vivo exercise
AU - Sylow, Lykke
AU - Møller, Lisbeth Liliendal Valbjørn
AU - Kleinert, Maximilian
AU - D'Hulst, Gommaar
AU - De Groote, Estelle
AU - Schjerling, Peter
AU - Steinberg, Gregory R
AU - Jensen, Thomas Elbenhardt
AU - Richter, Erik A.
N1 - CURIS 2017 NEXS 140
PY - 2017
Y1 - 2017
N2 - Exercise bypasses insulin resistance to increase glucose uptake in skeletal muscle and therefore represents an important alternative to stimulate glucose uptake in insulin resistant muscle. Both Rac1 and AMPK have been shown to partly regulate contraction-stimulated muscle glucose uptake but whether those two signaling pathways jointly account for the entire signal to glucose transport is unknown. We therefore studied the ability of contraction and exercise to stimulate glucose transport in isolated muscles with AMPK loss-of-function combined with either pharmacological inhibition or genetic deletion of Rac1.Muscle-specific knockout (mKO) of Rac1, a kinase dead α2 AMPK (α2KD), and double KO of β1 and β2 AMPK subunits (β1β2 KO), each partially decreased contraction-stimulated glucose transport in mouse soleus and EDL muscle. Interestingly, when pharmacological Rac1 inhibition was combined with either AMPK β1β2 KO or α2KD, contraction-stimulated glucose transport was almost completely inhibited. Importantly, α2KD+Rac1 mKO double-transgenic mice also displayed severely impaired contraction-stimulated glucose transport, while exercise-stimulated glucose uptake in vivo was only partially reduced by Rac1 mKO with no additive effect of α2KD. It is concluded that Rac1 and α2AMPK together account for almost the entire ex vivo contraction-response in muscle glucose transport, while only Rac1, but not α2AMPK, regulates muscle glucose uptake during submaximal exercise in vivo.
AB - Exercise bypasses insulin resistance to increase glucose uptake in skeletal muscle and therefore represents an important alternative to stimulate glucose uptake in insulin resistant muscle. Both Rac1 and AMPK have been shown to partly regulate contraction-stimulated muscle glucose uptake but whether those two signaling pathways jointly account for the entire signal to glucose transport is unknown. We therefore studied the ability of contraction and exercise to stimulate glucose transport in isolated muscles with AMPK loss-of-function combined with either pharmacological inhibition or genetic deletion of Rac1.Muscle-specific knockout (mKO) of Rac1, a kinase dead α2 AMPK (α2KD), and double KO of β1 and β2 AMPK subunits (β1β2 KO), each partially decreased contraction-stimulated glucose transport in mouse soleus and EDL muscle. Interestingly, when pharmacological Rac1 inhibition was combined with either AMPK β1β2 KO or α2KD, contraction-stimulated glucose transport was almost completely inhibited. Importantly, α2KD+Rac1 mKO double-transgenic mice also displayed severely impaired contraction-stimulated glucose transport, while exercise-stimulated glucose uptake in vivo was only partially reduced by Rac1 mKO with no additive effect of α2KD. It is concluded that Rac1 and α2AMPK together account for almost the entire ex vivo contraction-response in muscle glucose transport, while only Rac1, but not α2AMPK, regulates muscle glucose uptake during submaximal exercise in vivo.
KW - Journal Article
U2 - 10.2337/db16-1138
DO - 10.2337/db16-1138
M3 - Journal article
C2 - 28389470
VL - 66
SP - 1548
EP - 1559
JO - Diabetes
JF - Diabetes
SN - 0012-1797
IS - 6
ER -
ID: 176622223